Evolution of biomarker qualification at the health authorities
- 1 May 2010
- journal article
- Published by Springer Nature in Nature Biotechnology
- Vol. 28 (5) , 441-443
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug DevelopmentClinical Pharmacology & Therapeutics, 2009
- The innovative medicines initiative: a pre-competitive initiative to enhance the biomedical science base of Europe to expedite the development of new medicines for patientsDrug Discovery Today, 2008
- Strategic paths for biomarker qualificationToxicology, 2008
- A Prototypical Process for Creating Evidentiary Standards for Biomarkers and DiagnosticsClinical Pharmacology & Therapeutics, 2007
- [Tasks and expectations for drug design based on pharmacogenomics].2005